Chester County News and Community Website
WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) said its Board of Directors declared a regular quarterly cash dividend of $0.70 per share, payable on or about January 28, 2026, to …
InterDigital’s New Dividend Sparks Fresh Interest in Its Expanding Tech Portfolio Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NASDAQ: GBLI) announced that its Board of Directors approved a cash distribution of $0.35 per common share, scheduled for payment on December 30, …
Global Indemnity’s Surprise Year-End Payout Raises Big Questions for Investors Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) has deployed $2.45 million from its recent capital raise to acquire a basket of cryptocurrencies, marking a significant shift …
Onfolio’s $2.45M Crypto Bet Signals Bold Push Into Treasury Diversification Read More
WILMINGTON, DE — The Apache Software Foundation has promoted two open-source projects, Apache Artemis and Apache Wayang, to Top-Level Project status, recognizing their maturity, active communities and strategic relevance in …
Apache Artemis and Wayang Earn Top-Level Status as Open-Source Momentum Builds Read More
WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) expanded its development plan for NRX-101, amending its Investigational New Drug application to study the drug in combination with Transcranial Magnetic Stimulation …
NRx Eyes Faster Commercial Path as NRX-101 Moves Into TMS-Enhanced Depression Treatment Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) released a new strategic roadmap outlining how it plans to merge operating cash flow from its digital businesses with …
Onfolio Unveils Digital-Economy Roadmap as It Pivots Toward Dual-Engine Growth Read More WILMINGTON, DE — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) said the U.S. Food and Drug Administration has accepted its Abbreviated New Drug Application for KETAFREE, a preservative-free intravenous ketamine product that …
NRx’s Preservative-Free Ketamine Reaches FDA Review as Company Targets 2026 Launch Read More
WILMINGTON, DE — AstraZeneca secured U.S. approval for its IMFINZI (durvalumab) regimen in combination with FLOT chemotherapy for early-stage and locally advanced gastric and gastroesophageal junction cancers, marking the first …
AstraZeneca Wins Landmark Approval for IMFINZI Regimen in Early Gastric Cancer Read More
WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) appointed Richard Hoffman as executive vice president and general counsel, effective December 1, adding a seasoned life sciences attorney to its top ranks …
Incyte Names Veteran Biopharma Attorney as New General Counsel Read More
WILMINGTON, DE — Qnity Electronics, Inc. (NYSE: Q) secured a 2025 R&D 100 Award for its UV 26GNF photoresist, a new material designed to reduce environmental impact in semiconductor fabrication …
Revolutionary Chipmaking Material Wins Major Award as Industry Eyes Bold Shift Read More